Songwei Yang

Changsha, 410208, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Higenamine exerts an antidepressant effect by reducing neuronal damage induced by glutamate excitotoxicity: Based on crosstalk between astrocytes and neuron.

Higenamine exerts an antidepressant effect by reducing neuronal damage induced by glutamate excitotoxicity: Based on crosstalk between astrocytes and neuron.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: April 14, 2026

Corrigendum "Novel antidepressant mechanism of hypericin: Role of connexin 43-based gap junctions" [Biomed. Pharmacother. 167 (2023) 115545].

Corrigendum "Novel antidepressant mechanism of hypericin: Role of connexin 43-based gap junctions" [Biomed. Pharmacother. 167 (2023) 115545].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 10, 2026

Dihydromyricetin Ameliorates Myocardial Ischemia-Reperfusion Injury by Modulating CKLF1-Mediated Cardiomyocyte Pyroptosis.

Dihydromyricetin Ameliorates Myocardial Ischemia-Reperfusion Injury by Modulating CKLF1-Mediated Cardiomyocyte Pyroptosis.

Journal: Phytotherapy research : PTR

Published: October 13, 2025

Connexin43 and Its Regulation of Astrocyte Gap Junction Function: Influencing Depression Progression by Mediating Electrical and Chemical Signals.

Connexin43 and Its Regulation of Astrocyte Gap Junction Function: Influencing Depression Progression by Mediating Electrical and Chemical Signals.

Journal: CNS neuroscience & therapeutics

Published: April 28, 2025

Correction: Inflammasomes in neurodegenerative diseases.

Correction: Inflammasomes in neurodegenerative diseases.

Journal: Translational neurodegeneration

Published: January 24, 2025

Inflammasomes in neurodegenerative diseases.

Inflammasomes in neurodegenerative diseases.

Journal: Translational neurodegeneration

Published: August 23, 2024

Dihydromyricetin treats pulmonary hypertension by modulating CKLF1/CCR5 axis-induced pulmonary vascular cell pyroptosis.

Dihydromyricetin treats pulmonary hypertension by modulating CKLF1/CCR5 axis-induced pulmonary vascular cell pyroptosis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 29, 2024

Target modulation of glycolytic pathways as a new strategy for the treatment of neuroinflammatory diseases.

Target modulation of glycolytic pathways as a new strategy for the treatment of neuroinflammatory diseases.

Journal: Ageing research reviews

Published: July 26, 2024

Correction to: Exogenous Adenosine Antagonizes Excitatory Amino Acid Toxicity in Primary Astrocytes.

Correction to: Exogenous Adenosine Antagonizes Excitatory Amino Acid Toxicity in Primary Astrocytes.

Journal: Cellular and molecular neurobiology

Published: July 11, 2024

A bibliometric and visual analysis of research trends and hotspots of familial hypertrophic cardiomyopathy: A review.

A bibliometric and visual analysis of research trends and hotspots of familial hypertrophic cardiomyopathy: A review.

Journal: Medicine

Published: May 03, 2024

Corrigendum: Ginsenoside Rg1 ameliorates neuroinflammation via suppression of connexin43 ubiquitination to attenuate depression.

Corrigendum: Ginsenoside Rg1 ameliorates neuroinflammation via suppression of connexin43 ubiquitination to attenuate depression.

Journal: Frontiers in pharmacology

Published: April 17, 2024

Progress of Exosomal MicroRNAs and Traditional Chinese Medicine Monomers in Neurodegenerative Diseases.

Progress of Exosomal MicroRNAs and Traditional Chinese Medicine Monomers in Neurodegenerative Diseases.

Journal: Phytotherapy research : PTR

Published: January 01, 2024

Showing 1-12 of 30

Last Updated: 09/26/2026